116 related articles for article (PubMed ID: 27616637)
1. Loss of ASXL1 triggers an apoptotic response in human hematopoietic stem and progenitor cells.
Hilgendorf S; Folkerts H; Schuringa JJ; Vellenga E
Exp Hematol; 2016 Dec; 44(12):1188-1196.e6. PubMed ID: 27616637
[TBL] [Abstract][Full Text] [Related]
2. Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.
Davies C; Yip BH; Fernandez-Mercado M; Woll PS; Agirre X; Prosper F; Jacobsen SE; Wainscoat JS; Pellagatti A; Boultwood J
Br J Haematol; 2013 Mar; 160(6):842-50. PubMed ID: 23294243
[TBL] [Abstract][Full Text] [Related]
3. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
[TBL] [Abstract][Full Text] [Related]
4. Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells.
Gomez-Puerto MC; Folkerts H; Wierenga AT; Schepers K; Schuringa JJ; Coffer PJ; Vellenga E
Stem Cells; 2016 Jun; 34(6):1651-63. PubMed ID: 26930546
[TBL] [Abstract][Full Text] [Related]
5. Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells.
Salati S; Zini R; Bianchi E; Testa A; Mavilio F; Manfredini R; Ferrari S
Stem Cells; 2008 Apr; 26(4):950-9. PubMed ID: 18192237
[TBL] [Abstract][Full Text] [Related]
6. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
7. ASXL1 plays an important role in erythropoiesis.
Shi H; Yamamoto S; Sheng M; Bai J; Zhang P; Chen R; Chen S; Shi L; Abdel-Wahab O; Xu M; Zhou Y; Yang FC
Sci Rep; 2016 Jun; 6():28789. PubMed ID: 27352931
[TBL] [Abstract][Full Text] [Related]
8. HHEX promotes myeloid transformation in cooperation with mutant ASXL1.
Takeda R; Asada S; Park SJ; Yokoyama A; Becker HJ; Kanai A; Visconte V; Hershberger C; Hayashi Y; Yonezawa T; Tamura M; Fukushima T; Tanaka Y; Fukuyama T; Matsumoto A; Yamasaki S; Nakai K; Yamazaki S; Inaba T; Shibata T; Inoue D; Honda H; Goyama S; Maciejewski JP; Kitamura T
Blood; 2020 Oct; 136(14):1670-1684. PubMed ID: 32492700
[TBL] [Abstract][Full Text] [Related]
9. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
Wang J; Li Z; He Y; Pan F; Chen S; Rhodes S; Nguyen L; Yuan J; Jiang L; Yang X; Weeks O; Liu Z; Zhou J; Ni H; Cai CL; Xu M; Yang FC
Blood; 2014 Jan; 123(4):541-53. PubMed ID: 24255920
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
[TBL] [Abstract][Full Text] [Related]
11. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development.
Leeanansaksiri W; Wang H; Gooya JM; Renn K; Abshari M; Tsai S; Keller JR
J Immunol; 2005 Jun; 174(11):7014-21. PubMed ID: 15905544
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor and interleukin-3 induce stepwise generation of erythroid precursor cells from a basic fibroblast growth factor-dependent hematopoietic stem cell line, A-6.
Anzai H; Ikawa Y; Atsumi T
Biochem Biophys Res Commun; 2001 Apr; 282(4):940-6. PubMed ID: 11352642
[TBL] [Abstract][Full Text] [Related]
13. Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.
Ge G; Zhang P; Sui P; Chen S; Yang H; Guo Y; Rubalcava IP; Noor A; Delma CR; Agosto-Peña J; Geng H; Medina EA; Liang Y; Nimer SD; Mesa R; Abdel-Wahab O; Xu M; Yang FC
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917239
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
Reems JA; Mielcarek M; Torok-Storb B
Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.
Abdel-Wahab O; Gao J; Adli M; Dey A; Trimarchi T; Chung YR; Kuscu C; Hricik T; Ndiaye-Lobry D; Lafave LM; Koche R; Shih AH; Guryanova OA; Kim E; Li S; Pandey S; Shin JY; Telis L; Liu J; Bhatt PK; Monette S; Zhao X; Mason CE; Park CY; Bernstein BE; Aifantis I; Levine RL
J Exp Med; 2013 Nov; 210(12):2641-59. PubMed ID: 24218140
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
[TBL] [Abstract][Full Text] [Related]
17. Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates.
Zhang P; Chen Z; Li R; Guo Y; Shi H; Bai J; Yang H; Sheng M; Li Z; Li Z; Li J; Chen S; Yuan W; Cheng T; Xu M; Zhou Y; Yang FC
Cell Discov; 2018; 4():4. PubMed ID: 29423272
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
[TBL] [Abstract][Full Text] [Related]
19. Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down.
Liu YX; Dong X; Gong F; Su N; Li SB; Zhang HT; Liu JL; Xue JH; Ji SP; Zhang ZW
PLoS One; 2015; 10(8):e0135259. PubMed ID: 26252772
[TBL] [Abstract][Full Text] [Related]
20. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
